Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (9)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Danes, C.
Right arrow Articles by Vila, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Danes, C.
Right arrow Articles by Vila, J.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?


Journal of Antimicrobial Chemotherapy (2002) 50, 261-264
© 2002 The British Society for Antimicrobial Chemotherapy

Distribution of ß-lactamases in Acinetobacter baumannii clinical isolates and the effect of Syn 2190 (AmpC inhibitor) on the MICs of different ß-lactam antibiotics

Cristina Danes, Margarita M. Navia, Joaquim Ruiz, Francesc Marco, Angels Jurado, M. Teresa Jimenez de Anta and Jordi Vila*

Servei de Microbiologia, Institut Clínic Infeccions i Immunologia (ICII), Hospital Clínic-IDIBAPS, University of Barcelona, Villarroel 170, 08036 Barcelona, Spain

Received 19 September 2001; returned 28 December 2001; revised 28 February 2002; accepted 21 April 2002

The distribution of ß-lactamases in a group of 20 epidemiologically well defined Acinetobacter baumannii clinical isolates and the in vitro activity of Syn 2190, a novel ß-lactamase AmpC inhibitor, were determined. Twenty-five per cent of the strains carried and expressed a TEM-type ß-lactamase, whereas 35% had an OXA-type ß-lactamase. In nine out of 11 (82%) ceftazidime-resistant and four out of 13 (30.7%) cefepime-resistant strains, the MIC of these ß-lactam antibiotics decreased when determined in the presence of Syn 2190. Thus, our results suggest that in a high percentage of A. baumannii clinical isolates the increased production of AmpC, in combination or not with other resistance mechanisms, contributes to the resistance pattern in A. baumannii to ß-lactams.

* Corresponding author. Tel: +34-93-2275522; Fax: +34-93-2275454; E-mail: vila{at}medicina.ub.es


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Antimicrob. Agents Chemother.Home page
S. Bratu, D. Landman, D. A. Martin, C. Georgescu, and J. Quale
Correlation of Antimicrobial Resistance with {beta}-Lactamases, the OmpA-Like Porin, and Efflux Pumps in Clinical Isolates of Acinetobacter baumannii Endemic to New York City
Antimicrob. Agents Chemother., September 1, 2008; 52(9): 2999 - 3005.
[Abstract] [Full Text] [PDF]


Home page
Clin. Microbiol. Rev.Home page
A. Y. Peleg, H. Seifert, and D. L. Paterson
Acinetobacter baumannii: Emergence of a Successful Pathogen
Clin. Microbiol. Rev., July 1, 2008; 21(3): 538 - 582.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
A. Ribera, F. Fernandez-Cuenca, A. Beceiro, G. Bou, L. Martinez-Martinez, A. Pascual, J. M. Cisneros, J. Rodriguez-Bano, J. Pachon, and J. Vila
Antimicrobial Susceptibility and Mechanisms of Resistance to Quinolones and {beta}-Lactams in Acinetobacter Genospecies 3
Antimicrob. Agents Chemother., April 1, 2004; 48(4): 1430 - 1432.
[Abstract] [Full Text] [PDF]


Home page
J Antimicrob ChemotherHome page
S. Corvec, N. Caroff, E. Espaze, C. Giraudeau, H. Drugeon, and A. Reynaud
AmpC cephalosporinase hyperproduction in Acinetobacter baumannii clinical strains
J. Antimicrob. Chemother., October 1, 2003; 52(4): 629 - 635.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.